The vaccine against the human papillomavirus
The vaccine against the human papillomavirus, GARDASIL 9, protects female sex from 9 to 26 years old against the infection of genital warts caused by 9 strains of HPV, which have been proven to have high incidence in the development of cervical, vaginal cancers, vulvar and anal. This vaccine also protects males between 9 and 26 years against anal cancer and genital warts caused by those same types of HPV.
Effectiveness of the vaccine
It is 97% effective in preventing infection with HPV types (6, 11, 16, 18, 31, 33, 45, 52 and 58), causing diseases of the cervix, vulva and vagina.
The medicament does not prevent 100% of cervical cancer types. Therefore, it is necessary for women to continue routine examinations for the detection of cervical cancer.
The medication does not cure cancer or genital warts, it only prevents infection if it is not HPV carrier yet.
How to receive the vaccine.
GARDASIL 9 is supplied in the form of intramuscular injections, usually in the arm. Its immunological treatment can be administered in 2 or 3 injections.
There are different vaccination programs depending on the age and the interval between vaccinations.
For people 9 to 14 years of age, the vaccine can receive in 2 doses or 3 doses.
For the 2-dose schedule, last injection should be administered 6-12 months after the first injection.
If the second dose is administered before the first 5 months have elapsed, the last dose should be administered 4 months after the second shot.
For the 3-dose schedule, the second dose should be administered 2 months after the first shot and the third, 6 months after the first shot.
For people 15 to 26 years of age, the vaccine is administered using a 3-dose schedule; the second dose should be administered 2 months after the first shot and the third, 6 months after the first shot.
Please read the Patient Information for GARDASIL 9 and discuss it with your child’s doctor, you can find it here.
The choice of the appropriate vaccination program is responsibility of your primary care physician. The physician Prescribing Information also is available here
IMPORTANT SAFETY INFORMATION
Anyone who is allergic to the ingredients of GARDASIL 9 or GARDASIL, including those severely allergic to yeast, should not receive the vaccine.
GARDASIL 9 was not studied in women who knew they were pregnant.
Side effects may include:
Urticaria at the vaccine site
Fainting can occur after you get the injection. Sometimes people who pass out can fall and hurt themselves. For this reason, your health professional may ask your child to sit or lie down for 15 minutes after your child receives GARDASIL 9. Some people who faint may tremble or stiffen.
Only a doctor or health professional can decide if GARDASIL 9 is right for your child.